“…We recently characterized a high-affinity receptor for the cardiotoxic vasoconstrictor peptides, the sarafotoxins (SRTX), and for the vasoconstrictor peptides, endothelins (ET), in the rat heart and brain, and demonstrated the association of this receptor with phosphoinositide hydrolysis [1][2][3][4][5]. The sarafotoxins (SRTX-a, SRTX-b and SRTX-c [6,7]) and their structurally related mammalian vasoconstrictor peptides the endothelins (ET-1, ET-2, ET-3) [8,9] (see fig.l) were found to share many similarities in binding to their receptor, in their ability to induce phosphoinositide hydrolysis, regional distribution ( [10] and references therein) and vasoconstrictive activities [8,9,11].…”